Over 16,000 people work in our Pharmaceutical, Vaccines and Consumer Healthcare R&D organisations, in major research centres around the world.
View by business
Find out more
Our approach to R&D
How we research new medicines
Our research focuses on science related to the immune system and human genetics, while leveraging advanced technologies including functional genomics, artificial intelligence and machine learning – all of this is driven by the multiplier effect of Science x Technology x Culture.
How we research new vaccines
We invest in scientific and technical excellence to develop and launch new innovative vaccines that meet the needs of patients and payers.
Consumer Healthcare research
GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and payers